Affiliations of authors: Group Health Research Institute, Group Health Cooperative, Seattle, WA (KJW, ESO, DLM, DSMB); Department of Medicine and Epidemiology and Biostatistics, General Internal Medicine Section, Department of Veterans Affairs, University of California, San Francisco, San Francisco, CA (KK); Division of Biostatistics, Department of Public Health Sciences, University of California Davis School of Medicine, Davis, CA (DLM, CYM); Department of Obstetrics and Gynecology, University of New Mexico, Albuquerque, NM (CYM); Department of Community and Family Medicine, Norris Cotton Cancer Center, Dartmouth Medical School, Hanover, NH (TO); Department of Surgery and Office of Health Promotion Research, University of Vermont, Burlington, VT (BLS); Department of Radiology, University of North Carolina, Chapel Hill, NC (LMH).
J Natl Cancer Inst. 2014 Jan;106(1):djt341. doi: 10.1093/jnci/djt341. Epub 2013 Dec 5.
Endogenous hormones and growth factors that increase mammographic breast density could increase ovarian cancer risk. We examined whether high breast density is associated with ovarian cancer risk.
We conducted a cohort study of 724,603 women aged 40 to 79 years with 2,506,732 mammograms participating in the Breast Cancer Surveillance Consortium from 1995 to 2009. Incident epithelial ovarian cancer was diagnosed in 1373 women. We used partly conditional Cox regression to estimate the association between breast density and 5-year risk of incident epithelial ovarian cancer overall and stratified by 10-year age group. All statistical tests were two-sided.
Compared with women with scattered fibroglandular densities, women with heterogeneously dense and extremely dense breast tissue had 20% and 18% increased 5-year risk of incident epithelial ovarian cancer (hazard ratio [HR] = 1.20, 95% confidence interval [CI] = 1.06 to 1.36; HR = 1.18, 95% CI = 0.93 to 1.50, respectively; P(trend) = .01). Among women aged 50 to 59 years, we observed a trend in elevated risk associated with increased breast density (P(trend) = .02); women with heterogeneously and extremely dense breast tissue had 30% (HR = 1.30; 95% CI = 1.03 to 1.64) and 65% (HR = 1.65; 95% CI = 1.12 to 2.44) increased risk, respectively, compared with women with scattered fibroglandular densities. The pattern was similar but not statistically significant at age 40 to 49 years. There were no consistent patterns of breast density and ovarian cancer risk at age 60 to 79 years.
Dense breast tissue was associated with a modest increase in 5-year ovarian cancer risk in women aged 50 to 59 years but was not associated with ovarian cancer at ages 40 to 49 or 60 to 79 years.
增加乳腺密度的内源性激素和生长因子可能会增加卵巢癌的风险。我们研究了高乳腺密度是否与卵巢癌风险相关。
我们对 1995 年至 2009 年间参加乳腺癌监测联盟的 724603 名年龄在 40 至 79 岁的女性进行了队列研究,这些女性共进行了 2506732 次乳房 X 光检查。在 1373 名女性中诊断出上皮性卵巢癌。我们使用部分条件 Cox 回归估计了乳腺密度与上皮性卵巢癌整体 5 年发病风险之间的关系,并按 10 年年龄组进行分层。所有统计检验均为双侧检验。
与具有散在纤维腺体密度的女性相比,具有异质性致密和极度致密乳腺组织的女性上皮性卵巢癌的 5 年发病风险分别增加 20%(危险比[HR] = 1.20,95%置信区间[CI] = 1.06 至 1.36)和 18%(HR = 1.18,95% CI = 0.93 至 1.50;趋势 P 值<.01)。在 50 至 59 岁的女性中,我们观察到与乳腺密度增加相关的风险升高趋势(趋势 P 值<.02);与具有散在纤维腺体密度的女性相比,异质性和极度致密乳腺组织的女性风险分别增加 30%(HR = 1.30;95% CI = 1.03 至 1.64)和 65%(HR = 1.65;95% CI = 1.12 至 2.44)。在 40 至 49 岁的年龄组中,这种模式相似,但无统计学意义。在 60 至 79 岁的年龄组中,乳腺密度与卵巢癌风险之间没有一致的模式。
在 50 至 59 岁的女性中,致密的乳腺组织与卵巢癌 5 年发病风险略有增加相关,但与 40 至 49 岁或 60 至 79 岁的卵巢癌无关。